Complications Related To Activity After Pediatric Both Bone Fractures: Exploring the Effects of Activity on Fracture Displacement

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-18
SponsorVanderbilt University Medical Center

About this trial

The goal of this randomized clinical study is to understand the effect of activity on the re-displacement of pediatric forearm fractures in patients ages 8-18 years old excluding those with known metabolic bone disease or obvious refracture. The main questions the study aims to answer are:

Does increased activity lead to increased re-displacement rates during the treatment of pediatric forearm fractures? Are there complications associated with increased levels of activity during the treatment of pediatric forearm fractures (skin irritation, need for re-casting, operation)? Do activity restrictions provided for pediatric forearm fractures influence patient activity levels?

Participants will be randomized into activity-restricted vs activity-limited (no contact sports). Some patients will be provided an ActiGraph Activity tracker to monitor patient activity. Every patient will complete a validated activity survey (PAQ) to assess activity at each follow-up appointment. Activity data and any complications will be recorded from time of initial presentation to cast removal.

Eligibility criteria

Qualifiers

Isolated Distal Radius Metaphyseal Fx (with or without ulna styloid)

Distal Third (<4 cm from physis) Radius and Ulna fracture (i.e. without obvious physeal involvement)

Insolated Radial Shaft Fracture (diaphyseal)

Radial and Ulna Shaft Fracture (diaphyseal)

Disqualifiers

Initial presentation >7 days from the time of injury

Pathologic fracture

Any patient with metabolic bone disease (ex. Osteoporosis, skeletal dysplasias)

Any patient with known bone fragility condition (ex. Osteogenesis imperfecta)

Trial design

Treatments tested in this trial

  • Restricted Activity Reccomendations
  • Full Activity/Limited Activity Reccomendations

Treatment groups

100 Participants
are divided into 2 treatment groups